Coloradans are very fortunate to have the Anschutz Medical Campus close by, and we often take for granted the national (and international) leaders in medicine who practice there. Fortunately, one of these leaders, specifically, in the specialization of brain research, Dr. Huntington Potter, has agreed to speak to City Club on March 7.
Dr. Potter is Director of the Rocky Mountain Alzheimer’s Disease Center and a Professor in the CU Department of Neurology. Among many research projects, his team’s current research is devoted to laboratory and clinical investigation of neurodegenerative diseases, particularly Alzheimer’s disease (AD) and trisomy 21/Down syndrome (DS), which also induces AD by age 40 as well as possible defenses within rheumatoid arthritis patients.
Given the increasing incidence of Alzheimer’s and its toll on both patients and families, don’t miss this opportunity to hear from an expert with extraordinary qualifications about an important topic for people of all ages.
About Huntington Potter, Ph.D.:
Huntington Potter received his A.B. in Physics and Chemistry, cum laude from Harvard in 1972 and his Masters in Biochemistry and Molecular Biology from Harvard in 1975. Since then, his list of professional accomplishments is far too great to list in this abbreviated biography. For example, just one of his many accomplishments is his role as founding CEO and Scientific Director of the Byrd Alzheimer’s Institute which is the largest in the world.
Throughout his work, Dr. Potter has always maintained a broad interest in many aspects of neuroscience, genetics, immunology, biochemistry and cell biology and most recently in applying this knowledge to the problems of brain disease, with particular focus on the relationship between Down syndrome and Alzheimer’s disease.
ON THE MENU
Crisp Romaine & Iceberg Lettuces, Roma Tomato
Pan Seared Salmon with Lemon Chive Beurre Blanc
Portobello Ravioli, Roasted Zucchini, Oven-Dried Tomato & Truffle Bechamel